The Lattice flow diverter for the treatment of intracranial aneurysms: a single center experience in 117 consecutive aneurysms
- 12 June 2025
- journal article
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (4) , 1126-1132
Abstract
Background Flow diversion has revolutionized the management of intracranial aneurysms. This study aimed to evaluate the preliminary safety and efficacy profile of the novel Lattice flow diverter (LFD) in clinical applications. Methods We retrospectively analyzed consecutive patients with intracranial aneurysms who were treated with the LFD between June 2023 and May 2024. Based on the medical records and imaging data, we collected demographic characteristics, aneurysm features, procedural details, perioperative complications, clinical outcomes, and imaging results. Results This study comprised 105 patients (mean age, 55.4±9.04 years; 72.4% female) with 117 aneurysms, including 104 (88.9%) anterior circulation aneurysms. Procedural success was achieved in all patients (109 devices deployed). Adjunctive techniques included coiling in 39 aneurysms (33.3%) and balloon-assisted wall apposition in three cases (2.6%). The overall perioperative complication rate was 5.8%, with neurological complications (all ischemic events) occurring in 2.9% of cases. Clinical follow-up (mean 10.0±1.4 months) demonstrated preserved functional independence (modified Rankin Scale (mRS) score 0–2) in 98.0% of patients. Imaging follow-up (mean 6.6±1.6 months) revealed complete occlusion in 71.9% of aneurysms and adequate occlusion (Raymond–Roy class I/II) in 88.6%. Conclusion The LFD demonstrated favorable safety and efficacy characteristics for intracranial aneurysm treatment during short-term follow-up. Long-term outcomes require validation in multicenter prospective cohort studies.Keywords
This publication has 21 references indexed in Scilit:
- Safety and effectiveness assessment of the surpass evolve (SEASE): a post-market international multicenter studyJournal of NeuroInterventional Surgery, 2024
- Vanguard Study: Initial experience with the new fourth generation Pipeline Vantage Flow Diverter (PVFD): 6-month results, technical and clinical considerationsJournal of NeuroInterventional Surgery, 2024
- Retrograde placement of flow diversion for the treatment of giant internal carotid artery aneurysmJournal Of Neuroradiology, 2023
- Pipeline Embolization Devices for the Treatment of Intracranial Aneurysms, Single-Center Registry: Long-Term Angiographic and Clinical Outcomes from 1000 AneurysmsNeurosurgery, 2021
- Review of current intracranial aneurysm flow diversion technology and clinical useJournal of NeuroInterventional Surgery, 2020
- Safety and Effectiveness of the Pipeline Flex Embolization Device With Shield Technology for the Treatment of Intracranial Aneurysms: Midterm Results From a Multicenter StudyNeurosurgery, 2019
- Prospective study on embolization of intracranial aneurysms with the pipeline device: the PREMIER study 1 year resultsJournal of NeuroInterventional Surgery, 2019
- SAFE study (Safety and efficacy Analysis of FRED Embolic device in aneurysm treatment): 1-year clinical and anatomical resultsJournal of NeuroInterventional Surgery, 2018
- Treatment of complex anterior cerebral artery aneurysms with Pipeline flow diversion: mid-term resultsJournal of NeuroInterventional Surgery, 2016
- International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusionThe Lancet, 2005